Indefinite Delivery Contract 75D30120D07516
Award Date
4/1/20
Last Date to Order
3/31/21
Federal Agency
CDC Pittsburgh
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a $2,993,341,000 ceiling value and a period of performance from April 1, 2021 through March 31, 2022. The purpose of this IDC is to provide a range of standard pediatric vaccines required to support immunization...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), to Merck Sharp & Dohme LLC, doing business as Merck, to provide a variety of pediatric vaccines in support of the CDC's Immunization Awardees program and Vaccines for Children program. The contract has a ceiling value of $4,079,096,100 and a period of performance from April 1, 2024 through March 31, 2025. The...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the U.S. federal government. The contract has a total ceiling value of $3,942,689,200 and a period of performance from April 1, 2023 through March 31, 2024. The purpose of this IDC is to establish contracts for the purchase of a minimum of 100 doses up to maximum quantities...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a ceiling value of $4,116,159,200 and a period of performance from April 1, 2025 to March 30, 2026. The IDC is for the procurement of standard commercial pediatric vaccines to support the Vaccines for Children (VFC) program, which provides immunizations...
The Centers for Disease Control and Prevention (CDC) has awarded an Indefinite Delivery Contract (IDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of up to 23 standard pediatric vaccines. The $3.301 billion contract will run from April 1, 2022 through March 31, 2023, supporting the CDC's Immunization Awardees and the Vaccines for Children program under Section 317(j) of the Public Health Service Act. The vaccines being procured include a wide range such as DTaP, Hep...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, valued at a ceiling of $66,688,290, is for the procurement of adult vaccines under the VACCINES major program code. The contract has a period of performance from July 1, 2025 to June 30, 2026. As an established federal contractor, Merck holds several significant IDVs with the CDC,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to provide a range of standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The $1.6 billion multiple-award IDC has a period of performance from April 1, 2021 through March 31, 2022, with no small business set-asides utilized. The...
The Centers for Disease Control and Prevention (CDC) has awarded a multiple-award Indefinite Delivery Contract (IDC) valued up to $69,520,654.32 to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a period of performance from July 1, 2024 to June 30, 2025 and does not involve any set-aside designations. The IDC requires Merck, as a pharmaceutical manufacturer, to provide a wide range of adult vaccines including Hepatitis A,...
The key points from the provided information are as follows: This is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to the prime contractor Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a ceiling value of $86,407,050 and a period of performance from July 1, 2019 to June 30, 2020. The purpose of this IDC is to provide a wide range of vaccines for adults, including MMR, varicella,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to procure a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The contract has a ceiling value of $1,914,795,500.00 and a period of performance from April 1, 2024 through March 31, 2025. The solicitation sought offers for 27 different pediatric vaccines including vaccines for diseases such as dengue, diphtheria,...